nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.067	0.067	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bile duct cancer	0.0435	0.0435	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.0394	0.0394	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.0364	0.0364	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SOX17—bile duct cancer	0.0351	0.0351	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—bile duct cancer	0.029	0.029	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—HRAS—bile duct cancer	0.0255	0.0255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Estrogen signaling pathway—GNAS—bile duct cancer	0.0252	0.0252	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.0194	0.0194	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—SMAD4—bile duct cancer	0.0186	0.0186	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—FAR2—bile duct cancer	0.0175	0.0175	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.0165	0.0165	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.0157	0.0157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—SMAD4—bile duct cancer	0.015	0.015	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.0141	0.0141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.0132	0.0132	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.0117	0.0117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—SMAD4—bile duct cancer	0.0109	0.0109	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—SMAD4—bile duct cancer	0.0109	0.0109	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SMAD4—bile duct cancer	0.0102	0.0102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bile duct cancer	0.00996	0.00996	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—MMP2—bile duct cancer	0.00977	0.00977	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bile duct cancer	0.00969	0.00969	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.00904	0.00904	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—bile duct cancer	0.00891	0.00891	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—NOS2—bile duct cancer	0.00867	0.00867	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—FAR2—bile duct cancer	0.00866	0.00866	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—IDH2—bile duct cancer	0.00856	0.00856	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00816	0.00816	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—HRAS—bile duct cancer	0.00789	0.00789	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00778	0.00778	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.00757	0.00757	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TGFBR2—bile duct cancer	0.00754	0.00754	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—bile duct cancer	0.00753	0.00753	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bile duct cancer	0.00749	0.00749	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—MMP2—bile duct cancer	0.00744	0.00744	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—IDH1—bile duct cancer	0.00736	0.00736	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—SMAD4—bile duct cancer	0.00713	0.00713	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.00664	0.00664	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00606	0.00606	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00591	0.00591	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bile duct cancer	0.00581	0.00581	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.00576	0.00576	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.00572	0.00572	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bile duct cancer	0.00569	0.00569	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00552	0.00552	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—SMAD4—bile duct cancer	0.0055	0.0055	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00547	0.00547	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—ERBB2—bile duct cancer	0.00538	0.00538	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—ERBB2—bile duct cancer	0.00521	0.00521	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00521	0.00521	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RNF43—bile duct cancer	0.00505	0.00505	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—bile duct cancer	0.00489	0.00489	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MMP9—bile duct cancer	0.00488	0.00488	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.00486	0.00486	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC5A5—bile duct cancer	0.00486	0.00486	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP9—bile duct cancer	0.00481	0.00481	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MBD2—bile duct cancer	0.00461	0.00461	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00455	0.00455	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.00455	0.00455	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00445	0.00445	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00443	0.00443	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00442	0.00442	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IDH1—bile duct cancer	0.00434	0.00434	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—IDH2—bile duct cancer	0.00423	0.00423	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—bile duct cancer	0.00422	0.00422	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TGFB1—bile duct cancer	0.00412	0.00412	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—bile duct cancer	0.00405	0.00405	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—bile duct cancer	0.00404	0.00404	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—bile duct cancer	0.00402	0.00402	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—NRAS—bile duct cancer	0.00397	0.00397	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—bile duct cancer	0.00396	0.00396	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00385	0.00385	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GNAS—bile duct cancer	0.00377	0.00377	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—IDH1—bile duct cancer	0.00364	0.00364	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—bile duct cancer	0.00361	0.00361	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.0036	0.0036	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RNF43—bile duct cancer	0.00354	0.00354	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MBD2—bile duct cancer	0.00352	0.00352	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—bile duct cancer	0.00347	0.00347	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KRAS—bile duct cancer	0.00341	0.00341	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—bile duct cancer	0.00331	0.00331	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00331	0.00331	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—bile duct cancer	0.00326	0.00326	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00324	0.00324	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—ERBB2—bile duct cancer	0.00306	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—bile duct cancer	0.00303	0.00303	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—HRAS—bile duct cancer	0.003	0.003	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—bile duct cancer	0.00298	0.00298	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00294	0.00294	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—HRAS—bile duct cancer	0.0029	0.0029	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.00287	0.00287	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RNF43—bile duct cancer	0.00279	0.00279	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—bile duct cancer	0.00278	0.00278	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.00277	0.00277	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MBD2—bile duct cancer	0.00271	0.00271	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MBD2—bile duct cancer	0.00267	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.00263	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.00261	0.00261	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00255	0.00255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00249	0.00249	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FAR2—bile duct cancer	0.00243	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—bile duct cancer	0.00241	0.00241	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC5A5—bile duct cancer	0.0024	0.0024	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00234	0.00234	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—NRAS—bile duct cancer	0.00233	0.00233	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.00232	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFBR2—bile duct cancer	0.00231	0.00231	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.0023	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00229	0.00229	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00226	0.00226	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.00225	0.00225	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00223	0.00223	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SMAD4—bile duct cancer	0.00218	0.00218	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00217	0.00217	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.00213	0.00213	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—bile duct cancer	0.00212	0.00212	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00207	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—bile duct cancer	0.00203	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.00201	0.00201	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KRAS—bile duct cancer	0.002	0.002	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FAR2—bile duct cancer	0.00198	0.00198	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00193	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00187	0.00187	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GNAS—bile duct cancer	0.00186	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—SMAD4—bile duct cancer	0.00186	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—bile duct cancer	0.00182	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.0018	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.00179	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00177	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—HRAS—bile duct cancer	0.0017	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00167	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RNF43—bile duct cancer	0.00164	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—bile duct cancer	0.00163	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS2—bile duct cancer	0.00163	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFBR2—bile duct cancer	0.00162	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00157	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GNAS—bile duct cancer	0.00156	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMAD4—bile duct cancer	0.00153	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00148	0.00148	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SMAD4—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FAR2—bile duct cancer	0.00131	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFBR2—bile duct cancer	0.00127	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GNAS—bile duct cancer	0.00123	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ERBB2—bile duct cancer	0.00122	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMAD4—bile duct cancer	0.00121	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—IDH2—bile duct cancer	0.00119	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SMAD4—bile duct cancer	0.00109	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SMAD4—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—IDH1—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—bile duct cancer	0.001	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—IDH2—bile duct cancer	0.000968	0.000968	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRAS—bile duct cancer	0.00093	0.00093	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—bile duct cancer	0.000864	0.000864	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB2—bile duct cancer	0.000856	0.000856	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—bile duct cancer	0.000847	0.000847	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—IDH1—bile duct cancer	0.000832	0.000832	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—bile duct cancer	0.0008	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR2—bile duct cancer	0.000748	0.000748	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—bile duct cancer	0.000734	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNAS—bile duct cancer	0.000722	0.000722	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMAD4—bile duct cancer	0.000708	0.000708	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—bile duct cancer	0.00068	0.00068	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB2—bile duct cancer	0.000675	0.000675	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC5A5—bile duct cancer	0.000674	0.000674	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRAS—bile duct cancer	0.000651	0.000651	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—bile duct cancer	0.000651	0.000651	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000638	0.000638	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000632	0.000632	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—bile duct cancer	0.000605	0.000605	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—bile duct cancer	0.000593	0.000593	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—bile duct cancer	0.000579	0.000579	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—bile duct cancer	0.000561	0.000561	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC5A5—bile duct cancer	0.000549	0.000549	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000549	0.000549	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNAS—bile duct cancer	0.000524	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000514	0.000514	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRAS—bile duct cancer	0.000514	0.000514	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—bile duct cancer	0.000498	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—bile duct cancer	0.000477	0.000477	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—bile duct cancer	0.000476	0.000476	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—bile duct cancer	0.000468	0.000468	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—bile duct cancer	0.000442	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNAS—bile duct cancer	0.000427	0.000427	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB2—bile duct cancer	0.000396	0.000396	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—bile duct cancer	0.000393	0.000393	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—bile duct cancer	0.000376	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000362	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—bile duct cancer	0.00036	0.00036	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—bile duct cancer	0.00034	0.00034	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRAS—bile duct cancer	0.000302	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—bile duct cancer	0.000275	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—bile duct cancer	0.000231	0.000231	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—bile duct cancer	0.000221	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—bile duct cancer	0.000211	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—bile duct cancer	0.000151	0.000151	CbGpPWpGaD
